| Product Code: ETC6207774 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Neuropathic Pain Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Neuropathic Pain Market - Industry Life Cycle |
3.4 Austria Neuropathic Pain Market - Porter's Five Forces |
3.5 Austria Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Austria Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Austria Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Austria Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Austria Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Austria Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Austria Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Austria Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain disorders in Austria |
4.2.2 Growing awareness about available treatment options for neuropathic pain |
4.2.3 Technological advancements in pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neuropathic pain medications |
4.3.2 High cost associated with neuropathic pain treatments |
4.3.3 Limited access to specialized healthcare services in certain regions of Austria |
5 Austria Neuropathic Pain Market Trends |
6 Austria Neuropathic Pain Market, By Types |
6.1 Austria Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Austria Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Austria Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Austria Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Austria Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Austria Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Austria Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Austria Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Austria Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Austria Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Austria Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Austria Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Austria Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Austria Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Austria Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Austria Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Austria Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Austria Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Austria Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Austria Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Austria Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Austria Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Austria Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Austria Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Austria Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Austria Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Austria Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Austria Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Austria Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Austria Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Austria Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Austria Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Austria Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Austria Neuropathic Pain Market Export to Major Countries |
7.2 Austria Neuropathic Pain Market Imports from Major Countries |
8 Austria Neuropathic Pain Market Key Performance Indicators |
8.1 Patient satisfaction rate with neuropathic pain treatments |
8.2 Adoption rate of innovative pain management technologies in Austria |
8.3 Number of clinical trials and research studies focused on neuropathic pain treatments in the country |
9 Austria Neuropathic Pain Market - Opportunity Assessment |
9.1 Austria Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Austria Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Austria Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Austria Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Austria Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Austria Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Austria Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Austria Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Austria Neuropathic Pain Market - Competitive Landscape |
10.1 Austria Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Austria Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here